Syros Pharmaceuticals, Inc.
No trades
No trades
Compare with Syros Pharmaceuticals, Inc.
26.83 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Details
Sector
Industry
Website
Headquarters
Cambridge
Founded
2011
IPO date
Jun 30, 2016
ISIN
US87184Q2066
CUSIP
87184Q206
FIGI
BBG00D1PV170
Identifiers
ISIN US87184Q2066
Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of SYRS is 0.000100 USD — it hasn't changed in the past 24 hours. Watch Syros Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Syros Pharmaceuticals, Inc. stocks are traded under the ticker SYRS.
SYRS stock hasn't changed in a week, the month change is a −75.00% fall, over the last year Syros Pharmaceuticals, Inc. has showed a −90.91% decrease.
SYRS reached its all-time high on Aug 7, 2017 with the price of 2,437.500000 USD, and its all-time low was 0.000001 USD and was reached on Mar 31, 2026. View more price dynamics on SYRS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SYRS stock is 300.00% volatile and has beta coefficient of 14.91. Track Syros Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Syros Pharmaceuticals, Inc. there?
Yes, you can track Syros Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Syros Pharmaceuticals, Inc. is going to release the next earnings report on Aug 10, 2026. Keep track of upcoming events with our Earnings Calendar.
No, SYRS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SYRS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Syros Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Syros Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Syros Pharmaceuticals, Inc. stock shows the sell signal. See more of Syros Pharmaceuticals, Inc. technicals for a more comprehensive analysis.